Corbion NV

Затворен

СекторФинансови

17.6 -0.23

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

17.54

Максимум

17.63

Ключови измерители

By Trading Economics

Препоръки

By TipRanks

Препоръки

Купи

12-месечна прогноза

+34.03% upside

Настроения в новините

By Acuity

50%

50%

205 / 529 Класиране в Finance

Corbion NV Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

31.10.2025 г., 17:40 ч. UTC

Придобивния, сливания и поглъщания

Orange to Buy Lorca's 50% Stake in MasOrange for $4.9 Billion

1.11.2025 г., 12:56 ч. UTC

Печалби

Berkshire's Quarterly Earnings Rise After Insurance Results Improve -- WSJ

1.11.2025 г., 12:56 ч. UTC

Печалби

Berkshire Operating Profits Rose 33% in Third Quarter. There Were No Stock Buybacks. -- Barrons.com

1.11.2025 г., 12:20 ч. UTC

Печалби

Berkshire Operating Profits Rose 33% in Third Quarter. There Were No Stock Buybacks. -- Barrons.com

1.11.2025 г., 12:19 ч. UTC

Печалби

Berkshire Operating Profits Rose 33% in Third Quarter. There Were No Stock Buybacks. -- Barrons.com

1.11.2025 г., 08:20 ч. UTC

Пазарно говорене

Financial Services Roundup: Market Talk

1.11.2025 г., 08:20 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

1.11.2025 г., 00:10 ч. UTC

Печалби

Trouble on The Strip -- Barrons.com

31.10.2025 г., 23:09 ч. UTC

Печалби

Review & Preview: October Surprise -- Barrons.com

31.10.2025 г., 22:44 ч. UTC

Придобивния, сливания и поглъщания

Pfizer Sues Seeking to Block Novo Nordisk's Effort to Undo Weight-Loss Drug Deal -- WSJ

31.10.2025 г., 21:25 ч. UTC

Пазарно говорене
Придобивния, сливания и поглъщания

Pfizer Says Novo Nordisk's Metsera Bid Won't Pass Antitrust Laws -- Market Talk

31.10.2025 г., 21:20 ч. UTC

Придобивния, сливания и поглъщания

Pfizer Sues Seeking to Block Novo Nordisk's Effort to Undo Weight-Loss Drug Deal -- Update

31.10.2025 г., 21:12 ч. UTC

Придобивния, сливания и поглъщания

Pfizer Sues Metsera, Novo Nordisk, Claiming Novo Nordisk Takeover Offer Isn't Superior -- WSJ

31.10.2025 г., 21:12 ч. UTC

Придобивния, сливания и поглъщания

Pfizer Sues Seeking to Block Novo Nordisk's Effort to Undo Weight-Loss Drug Deal -- WSJ

31.10.2025 г., 21:12 ч. UTC

Придобивния, сливания и поглъщания

Pfizer Seeks Order Blocking Metsera From Terminating Its Merger Deal With Pfizer -- WSJ

31.10.2025 г., 20:51 ч. UTC

Придобивния, сливания и поглъщания

Another Rare-Earth Stock Jumps on Government Deal -- Barrons.com

31.10.2025 г., 20:50 ч. UTC

Пазарно говорене

Financial Services Roundup: Market Talk

31.10.2025 г., 20:50 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

31.10.2025 г., 20:50 ч. UTC

Пазарно говорене
Печалби

Auto & Transport Roundup: Market Talk

31.10.2025 г., 20:46 ч. UTC

Придобивния, сливания и поглъщания

Pfizer: Files Lawsuit Against Metsera and Its Directors and Novo Nordisk for Breach of Merger Agreement

31.10.2025 г., 20:22 ч. UTC

Печалби

Amazon Stock Hits New Record. What Was So Good in Its Earnings Report. -- Barrons.com

31.10.2025 г., 20:02 ч. UTC

Печалби

Meta Faces a Sudden Reckoning. How Big Tech Earnings Are Reshaping the AI Race. -- Barrons.com

31.10.2025 г., 19:55 ч. UTC

Пазарно говорене

Crude Futures Fall for Third Straight Month -- Market Talk

31.10.2025 г., 19:54 ч. UTC

Придобивния, сливания и поглъщания

Pfizer: FTC Granted Early Termination of Waiting Period >PFE

31.10.2025 г., 19:54 ч. UTC

Придобивния, сливания и поглъщания

Pfizer: Receives Early Clearance From FTC for Metsera Acquisition

31.10.2025 г., 19:26 ч. UTC

Пазарно говорене

U.S. Natural Gas Rises on Winter Outlook, Strong LNG -- Market Talk

31.10.2025 г., 18:30 ч. UTC

Печалби

These Stocks Are Moving the Most Today: Amazon, Nvidia, Apple, Netflix, Exxon, DexCom, Coinbase, Reddit, Newell Brands, and More -- Barrons.com

31.10.2025 г., 18:23 ч. UTC

Пазарно говорене

Gold Edges Lower for the Day, Closes October Positive -- Market Talk

31.10.2025 г., 18:09 ч. UTC

Печалби

Bank of America Has a Game Plan to Catch Up to Its Peers. It's Time to Buy the Stock. -- Barrons.com

31.10.2025 г., 18:08 ч. UTC

Печалби

Bank of America Has a Game Plan to Catch Up to Its Peers. It's Time to Buy the Stock. -- Barrons.com

Corbion NV Прогноза

Ценова цел

By TipRanks

34.03% нагоре

12-месечна прогноза

Среден 23.67 EUR  34.03%

Висок 31 EUR

Нисък 18 EUR

Според 3 анализатори от Wall Street, предложили 12-месечна ценова цел за Corbion NV през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

3 ratings

2

Купи

1

Задържане

0

Продай

Настроение

By Acuity

205 / 529 Класиране в Финансови

Настроения в новините

Neutral

Волатилност

Под средното

Обем новини (RCV)

Над средното

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно Corbion NV

Corbion N.V. provides lactic acid and lactic acid derivatives, other ferment, functional enzyme blends, minerals, vitamins, and algae ingredients worldwide. It offers ingredient solutions for the food, home and personal care, animal nutrition, supplements, pharmaceuticals, medical devices, and bioplastics markets. The company markets its products through a network of sales offices and distributors. The company was formerly known as CSM N.V. and changed its name to Corbion N.V. in October 2013. Corbion N.V. was incorporated in 1919 and is headquartered in Amsterdam, the Netherlands.
help-icon Live chat